Title
Category
Credits
Event date
Cost
Basic Immunology: Introduction to Immune Cells and Innate and Adaptive Immunity
  • 1.00 Participation
$25.00
The "Basic Immunology: Introduction to Immune Cells and Innate and Adaptive Immunity" is lead by Dr. Wendy  Jo  Freebern  PhD. DABT, Global leader, Hematologic and Immunologic toxicology  (HIT), Predictive, Investigative and Translational Toxicology (PITT), Preclinical Sciences and Translational Toxicology (PITT), Preclinical Sciences and Translational Safety- Janssen Pharmaceutical Companies of Johnson and Johnson.    
Immunogenicity characterization tools (ADAs, complement, immune complexes)
  • Immunosafety
  • 0.50 Participation
$25.00
Welcome!We are delighted that you have chosen the Immuno-Safety Tools module to start or enhance your current educational journey in immuno-safety science. This lecture is one in a series of seven providing detailed information on tools currently used to evaluate and characterize the status of the immune system in a preclinical setting.
HESI Human health and Safety
  • 0.50 Participation
$0.00
Welcome to the HESI ITC On-demand training course.  We are delighted that you have chosen this introduction module to start or enhance your current educational journey in immuno-safety science.This course is 1 of 18 courses included in the Introduction to Immuno-Safety Science and is led by HESI's Executive Director, Dr. Syril Pettit PhD. If you are new to HESI and would like to learn more about our organization, please take a moment to visit our website at  https://hesiglobal.org/   
Natural Killer Cells and Their Use for Cancer Immunotherapy
  • 1.00 Participation
$35.00
Welcome!We are delighted that you have chosen to enhance your educational journey in immuno-safety science by enrolling in this module. The "Natural Killer Cells and Their Use for Cancer Immunotherapy" lecture is one in a series of ten lectures included in the Cancer Immunotherapies module and is led by Dr. Alexandre Iannello at Sonoma Biotherapeutics.
Immunopathology: Evaluation from Discovery to Safety Assessment
  • Immunosafety
  • 1.00 Participation
$35.00
Welcome!We are delighted that you have chosen the Immuno-Safety Tools module to start or enhance your current educational journey in immuno-safety science. This lecture is one in a series of seven providing detailed information on tools currently used to evaluate and characterize the status of the immune system in a preclinical setting and is led by Dr. Tracy Papenfuss at StageBio.
TDAR assessments
  • 1.00 Participation
$35.00
Welcome!We are delighted that you have chosen the Immuno-Safety Tools module to start or enhance your current educational journey in immuno-safety science. This lecture is one in a series of six providing detailed information on tools currently used to evaluate and characterize the status of the immune system in a preclinical setting and is led by Dr. Carolyne Dumont at Charles River.
Immunophenotyping
  • Immunosafety
  • 1.00 Participation
$35.00
Welcome!We are delighted that you have chosen the Immuno-Safety Tools module to start or enhance your current educational journey in immuno-safety science. This lecture is one in a series of six providing detailed information on tools currently used to evaluate and characterize the status of the immune system in a preclinical setting and is led by Dr. Birgit Fogal at Boehringer Ingelheim.
Systems Biology Applied to Immune Safety
  • Immunosafety
  • 1.00 Participation
$35.00
Welcome!We are delighted that you have chosen the Immuno-Safety Tools module to start or enhance your current educational journey in immuno-safety science. This lecture is one in a series of six providing detailed information on tools currently used to evaluate and characterize the status of the immune system in a preclinical setting and is led by Dr. Holden Maecker at Stanford University.
CAR Therapy
  • Immunosafety
  • 1.00 Participation
$35.00
Welcome!We are delighted that you have chosen the Therapeutic Modalities module to start or enhance your current educational journey in immuno-safety science. This lecture is one in a series of five providing detailed information on current and/or emerging therapeutics that interact with the immune system and is led by Dr. Cori Abikoff and Dr. Lauren Gauthier at Takeda Pharmaceuticals.
Safety Considerations for Oligonucleotides
  • Immunosafety
  • 1.00 Participation
$35.00
Welcome!We are delighted that you have chosen the Therapeutic Modalities module to start or enhance your current educational journey in immuno-safety science. This lecture is one in a series of five providing detailed information on current and/or emerging therapeutics that interact with the immune system and is led by Dr. Padmakumar Narayanan at WAVE Life Sciences.

Pages